Skip to content

Serotonin: all studies

Page 316 of 400: studies 3,151 to 3,160 of 3,999, newest first. Back to the serotonin overview

Research

Convergent Mechanisms Underlying Rapid Antidepressant Action.

CNS Drugs March 2018 Panos Zanos, Scott M. Thompson, Ronald S. Duman et al.

Traditional pharmacological treatments for depression have a delayed therapeutic onset, ranging from several weeks to months, and there is a high percentage of individuals who never respond to treatment. In contrast, ketamine produces rapid-onset antidepressant, anti-suicidal, and anti-anhedonic actions following a single administration to patients with depression. Proposed mechanisms of the...

Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine.

Toxicology mechanisms and methods March 2018 Daniel P Katz, Mohammed Majrashi, Sindhu Ramesh et al.

Benzylpiperazine has been designated as Schedule I substance under the Controlled Substances Act by Drug Enforcement Administration. Benzylpiperazine is a piperazine derivative, elevates both dopamine and serotonin extracellular levels producing stimulatory and hallucinogenic effects, respectively, similar to methylenedioxymethamphetamine (MDMA). However, the comparative neurotoxic effects of...

DOI: 10.1080/15376516.2017.1376024 (opens in new tab) Full text (opens in new tab) Piperazine designer drugs Apoptosis Mitochondrial functions Monoamine neurotransmission +1

Horizontal gene cluster transfer increased hallucinogenic mushroom diversity

Evolution Letters February 27, 2018 Hannah T. Reynolds, Vinod Vijayakumar, Emile Gluck‐thaler et al. 114 citations

Abstract Secondary metabolites are a heterogeneous class of chemicals that often mediate interactions between species. The tryptophan-derived secondary metabolite, psilocin, is a serotonin receptor agonist that induces altered states of consciousness. A phylogenetically disjunct group of mushroom-forming fungi in the Agaricales produce the psilocin prodrug, psilocybin. Spotty phylogenetic...

DOI: 10.1002/evl3.42 (opens in new tab) Full text (opens in new tab) Psilocybin Mushroom bodies Agaricales Horizontal gene transfer +2

Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)

ACS Chemical Neuroscience February 20, 2018 David E. Nichols 87 citations

Lysergic acid diethylamide (LSD) is one of the most potent psychoactive agents known, producing dramatic alterations of consciousness after submilligram (≥20 μg) oral doses. Following the accidental discovery of its potent psychoactive effects in 1943, it was supplied by Sandoz Laboratories as an experimental drug that might be useful as an adjunct for psychotherapy, or to give psychiatrists...

Psychedelics and the essential importance of context.

Journal of Psychopharmacology February 15, 2018 Robin Carhart-Harris, Leor Roseman, Eline Haijen et al. 646 citations

Psychedelic drugs are making waves as modern trials support their therapeutic potential and various media continue to pique public interest. In this opinion piece, we draw attention to a long-recognised component of the psychedelic treatment model, namely ‘set’ and ‘setting’ – subsumed here under the umbrella term ‘context’. We highlight: (a) the pharmacological mechanisms of classic...

DOI: 10.1177/0269881118754710 (opens in new tab) Psychedelics Hallucinogens Entheogens Psychedelic compounds +21

β2-Adrenergic Receptor Activation Suppresses the Rat Phenethylamine Hallucinogen-Induced Head Twitch Response: Hallucinogen-Induced Excitatory Post-synaptic Potentials as a Potential Substrate.

Frontiers in Pharmacology February 8, 2018 Gerard J. Marek, Brian P Ramos

5-Hydroxytryptamine2A (5-HT2A) receptors are enriched in layers I and Va of the rat prefrontal cortex and neocortex and their activation increases the frequency of glutamatergic excitatory postsynaptic potentials/currents (EPSP/Cs) onto layer V pyramidal cells. A number of other G-protein coupled receptors (GPCRs) are also enriched in cortical layers I and Va and either induce (1-adrenergic...

DOI: 10.3389/fphar.2018.00089 (opens in new tab) Full text (opens in new tab) Epinephrine Clenbuterol Ici-118,551 2,5-dimethoxy-4-iodoamphetamine doi

“Ecstasy” to Addiction: Mechanisms and Reinforcing Effects of Three Synthetic Cathinone Analogs of MDMA

Neuropharmacology January 31, 2018 Sean B. Dolan, Zhenglan Chen, Renqi Huang et al.

ABSTRACT This study aimed to address the mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA commonly reported in “Ecstasy” formulations: methylone, butylone, and pentylone. Whole‐cell patch clamp techniques were used to assess the mechanism of each compound at the dopamine and serotonin transporters. Separate groups of rats were trained to discriminate...

The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports

Frontiers in Neuroscience January 22, 2018 Camila Sanz, Federico Zamberlán, Earth Erowid et al. 112 citations

Ever since the modern rediscovery of psychedelic substances by Western society, several authors have independently proposed that their effects bear a high resemblance to the dreams and dreamlike experiences occurring naturally during the sleep-wake cycle. Recent studies in humans have provided neurophysiological evidence supporting this hypothesis. However, a rigorous comparative analysis of...

Dimetiltriptamina: alcalóide alucinógeno e seus efeitos no Sistema Nervoso Central

Acta Brasiliensis January 20, 2018 Darliane Freire Almeida, Thais Josy Castro Freire de Assis, Ana Ligia Pereira Silva 4 citations

Plantas alucinógenas são bastante utilizadas em rituais e cultos religiosos. O chá de Ayahuasca e o vinho da Jurema preta, bebidas alucinógenas, apresentam o alcalóide dimetiltriptamina (DMT), responsável pelo efeito alucinógeno devido a interação com receptores serotoninérgicos no sistema nervoso central (SNC). O objetivo da pesquisa foi esclarecer os mecanismos de ação e os efeitos da DMT...

Pharmacological and toxicological investigations of new psychoactive substances

edoc (University of Basel) 2018 Dino Lüthi

Since the mid-2000s, an unprecedented amount of new psychoactive substances (NPSs) have emerged on the recreational drug market and have since then gained popularity as alternatives to traditional drugs of abuse. Besides clinical case reports, the pharmacological profiling and assessment of toxicity in vitro provide valuable information on the mechanism of action and possible risks associated...